Drug repurposing of clinically approved drugs to target epithelial-mesenchymal transition using molecular docking approach
Introduction: Epithelial-mesenchymal transition (EMT) is a process of epithelial transformation into mesenchymal cells. It is also a process that contributes to the progression of fibrosis and cancer metastasis. Transforming growth factor-beta (TGF-²), as a potent inducer of EMT, has therefore becam...
Main Authors: | Chun Hao, Ong, Chau Ling, Tham, Harith, Hanis Hazeera, Firdaus, Nazmi, Ahmad Israf, Daud |
---|---|
Format: | Article |
Language: | English |
Published: |
Universiti Putra Malaysia Press
2023
|
Online Access: | http://psasir.upm.edu.my/id/eprint/107414/1/107414.pdf |
Similar Items
-
Drug repurposing of clinically-approved drugs to target epithelial-mesenchymal transition using in silico analysis
by: Ong, Chun Hao
Published: (2021) -
TGF-β-induced fibrosis: a review on the underlying mechanism and potential therapeutic strategies
by: Ong, Chun Hao, et al.
Published: (2021) -
Repurposing of potent drug candidates for multiparasite targeting
by: Jain, V, et al.
Published: (2017) -
A computational approach for drug repurposing towards Huntington's disease
by: Tham, Nevin Zihao
Published: (2025) -
Targeting NF-κB signaling in macrophages through drug repurposing
by: Roberti, A
Published: (2024)